UPDATE: FDA says pause of J&J vaccine will last “matter of days”


FILE – In this March 25, 2021 file photo, a box of the Johnson & Johnson COVID-19 vaccine is shown in a refrigerator at a clinic in Washington state. A batch of Johnson & Johnson’s COVID-19 vaccine failed quality standards and can’t be used, the drug giant said late Wednesday, March 31, 2021. The drugmaker didn’t say how many doses were lost, and it wasn’t clear how the problem would impact future deliveries. (AP Photo/Ted S. Warren)

UPDATE: 4/13/21 @ 10:30 A.M. (WLNS) FDA says pause of Johnson & Johnson COVID-19 vaccine to investigate clots to last ‘matter of days.’

<<<The Associated Press contributed to this report.

WASHINGTON (WLNS)– On Tuesday the FDA announced the agency was calling for a pause in the use of the Johnson & Johnson COVID-19 vaccine.

According to officials, as of yesterday, more than 6.8 million doses of the vaccine have been administered in the U.S. CDC & FDA are reviewing data involving 6 reported U.S. cases of a rare & severe type of blood clot in individuals after receiving the vaccine.

Right now, these adverse events appear to be extremely rare.

The CDC will convene a meeting of the Advisory Committee on Immunization Practices (ACIP) on Wednesday to further review these cases and assess their potential significance. The FDA will review that analysis as it also investigates these cases.

The FDA says they take vaccine side effects seriously, and will hold a news conference on YouTube at 10 A.M to provide more information.

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Michigan Headlines

More Michigan

StormTracker 6 Radar